163 related articles for article (PubMed ID: 9694710)
1. The distal cytoplasmic domain of the erythropoietin receptor induces granulocytic differentiation in 32D cells.
Harris KW; Hu XJ; Schultz S; Arcasoy MO; Forget BG; Clare N
Blood; 1998 Aug; 92(4):1219-24. PubMed ID: 9694710
[TBL] [Abstract][Full Text] [Related]
2. A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation.
Arcasoy MO; Harris KW; Forget BG
Exp Hematol; 1999 Jan; 27(1):63-74. PubMed ID: 9923445
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin hypersensitivity in primary familial and congenital polycythemia: role of tyrosines Y285 and Y344 in erythropoietin receptor cytoplasmic domain.
Arcasoy MO; Karayal AF
Biochim Biophys Acta; 2005 Apr; 1740(1):17-28. PubMed ID: 15878737
[TBL] [Abstract][Full Text] [Related]
4. Cytokine signals through STAT3 promote expression of granulocyte secondary granule proteins in 32D cells.
Wang L; Arcasoy MO; Watowich SS; Forget BG
Exp Hematol; 2005 Mar; 33(3):308-17. PubMed ID: 15730854
[TBL] [Abstract][Full Text] [Related]
5. Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.
Chin H; Arai A; Wakao H; Kamiyama R; Miyasaka N; Miura O
Blood; 1998 May; 91(10):3734-45. PubMed ID: 9573010
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
7. Familial polycythemia due to truncations of the erythropoietin receptor.
Forget BG; Degan BA; Arcasoy MO
Trans Am Clin Climatol Assoc; 2000; 111():38-44; discussion 44-5. PubMed ID: 10881330
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo.
Miura O; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Sep; 84(5):1501-7. PubMed ID: 8068943
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin induces tyrosine phosphorylation of the interleukin-3 receptor beta subunit (betaIL3) and recruitment of Stat5 to possible Stat5-docking sites in betaIL3.
Chin H; Wakao H; Miyajima A; Kamiyama R; Miyasaka N; Miura O
Blood; 1997 Jun; 89(12):4327-36. PubMed ID: 9192755
[TBL] [Abstract][Full Text] [Related]
10. Induction of tyrosine phosphorylation of Vav and expression of Pim-1 correlates with Jak2-mediated growth signaling from the erythropoietin receptor.
Miura O; Miura Y; Nakamura N; Quelle FW; Witthuhn BA; Ihle JN; Aoki N
Blood; 1994 Dec; 84(12):4135-41. PubMed ID: 7527668
[TBL] [Abstract][Full Text] [Related]
11. A constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell lines.
Shikama Y; Barber DL; D'Andrea AD; Sieff CA
Blood; 1996 Jul; 88(2):455-64. PubMed ID: 8695792
[TBL] [Abstract][Full Text] [Related]
12. CrkL is recruited through its SH2 domain to the erythropoietin receptor and plays a role in Lyn-mediated receptor signaling.
Arai A; Kanda E; Nosaka Y; Miyasaka N; Miura O
J Biol Chem; 2001 Aug; 276(35):33282-90. PubMed ID: 11443118
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-3 (IL-3) inhibits erythropoietin-induced differentiation in Ba/F3 cells via the IL-3 receptor alpha subunit.
Krosl J; Damen JE; Krystal G; Humphries RK
J Biol Chem; 1996 Nov; 271(44):27432-7. PubMed ID: 8910323
[TBL] [Abstract][Full Text] [Related]
14. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.
Tong W; Zhang J; Lodish HF
Blood; 2005 Jun; 105(12):4604-12. PubMed ID: 15705783
[TBL] [Abstract][Full Text] [Related]
15. The extended box 2 subdomain of erythropoietin receptor is nonessential for Jak2 activation yet critical for efficient mitogenesis in FDC-ER cells.
He TC; Jiang N; Zhuang H; Quelle DE; Wojchowski DM
J Biol Chem; 1994 Jul; 269(28):18291-4. PubMed ID: 8034573
[TBL] [Abstract][Full Text] [Related]
16. Increased cell surface expression of C-terminal truncated erythropoietin receptors in polycythemia.
Motohashi T; Nakamura Y; Osawa M; Hiroyama T; Iwama A; Shibuya A; Nakauchi H
Eur J Haematol; 2001 Aug; 67(2):88-93. PubMed ID: 11722595
[TBL] [Abstract][Full Text] [Related]
17. Expression of a constitutively active erythropoietin receptor in primary hematopoietic progenitors abrogates erythropoietin dependence and enhances erythroid colony-forming unit, erythroid burst-forming unit, and granulocyte/macrophage progenitor growth.
Pharr PN; Hankins D; Hofbauer A; Lodish HF; Longmore GD
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):938-42. PubMed ID: 7679218
[TBL] [Abstract][Full Text] [Related]
18. SHP-1 phosphatase C-terminus interacts with novel substrates p32/p30 during erythropoietin and interleukin-3 mitogenic responses.
Yang W; Tabrizi M; Berrada K; Yi T
Blood; 1998 May; 91(10):3746-55. PubMed ID: 9573011
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction.
Gobert S; Porteu F; Pallu S; Muller O; Sabbah M; Dusanter-Fourt I; Courtois G; Lacombe C; Gisselbrecht S; Mayeux P
Blood; 1995 Jul; 86(2):598-606. PubMed ID: 7541671
[TBL] [Abstract][Full Text] [Related]
20. Activation of the transcription factor NF-kappaB by the erythropoietin receptor: structural requirements and biological significance.
Bittorf T; Büchse T; Sasse T; Jaster R; Brock J
Cell Signal; 2001 Sep; 13(9):673-81. PubMed ID: 11495725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
